Cognition Therapeutics' Grant - III Round

Cognition Therapeutics raised a round of funding on October 02, 2018. Investors include National Institute of Aging.

Cognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting toxic proteins that cause the cognitive decline associated with Alzheimer's disease and othe…

Articles about Cognition Therapeutics' Grant - III Round: